TALKMED GROUP LTD

Name

TALKMED GROUP LTD

Legal name

TalkMed Group Limited

Website

https://talkmed.com.sg

Company type

Public

Founded year

2013

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Oncology Healthcare Services

NAICS

Offices of Physicians (except Mental Health Specialists) (621111), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industry

Hospital-Based Palliative Care (Inpatient Consult Services) (HLADAHAG)

Keywords

• Medical oncology services
• Palliative care services
• Cancer treatment
• Specialist healthcare
• Tertiary healthcare services

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D

Revenue model

1. Medical Oncology Services: Tertiary healthcare services in medical oncology provided through Parkway Cancer Centre (PCC) in Singapore's private healthcare sector
2. Palliative Care Services: Specialized palliative care services for oncology patients

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

TalkMed Group is a group of doctors providing tertiary healthcare services in medical oncology and palliative care to oncology patients in Singapore's private sector through Parkway Cancer Centre (PCC). Services cover specialized care for breast cancers, head and neck cancers, gastro-intestinal cancers, uro-gynaecological cancers, and haematology malignancies, complemented by ancillary health services and advanced medical technology services.

Product overview

TALKMED GROUP LTD is a healthcare services provider operating as a group of doctors offering tertiary healthcare services in two core areas: Medical Oncology and Palliative Care. The company provides specialized cancer treatment through Parkway Cancer Centre (PCC) in Singapore's private healthcare sector, with oncologists specializing in breast, head and neck, gastro-intestinal, uro-gynaecological cancers, and haematology malignancies. The portfolio includes core medical oncology and palliative care services supported by ancillary health services and advanced medical technology services. The group has expanded internationally through subsidiaries including TalkMed China Pte. Ltd. and Stem Med Pte. Ltd.

Differentiator

Problem solved

Functional benefit

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and regional.

• Riverside Group (山水文园集团)coreStrategic or Co-development Partner · 21 June 2019TalkMed China Pte. Ltd., a subsidiary of TalkMed Group Limited, entered into a collaboration framework agreement with Riverside Group for establishing a long-term strategic partnership in health management and provision of medical services to cities in China.
• TalkMed Medical Centre Pte. Ltd. (TMC)coreStrategic or Co-development Partner · 16 November 2017Entry by TalkMed subsidiary into Management Services Agreement and Licence Agreement for medical centre operations.
• Hong Kong Adventist Oncology CentercoreStrategic or Co-development Partner · 11 November 2016Hong Kong Integrated Oncology Centre Limited (subsidiary of associate Hong Kong Integrated Oncology Centre Holdings Limited) entered into strategic collaboration with Hong Kong Adventist Oncology Center to develop seamless multi-disciplinary cancer services in Hong Kong. The collaboration leads to simplified patient flow allowing multidisciplinary specialists to provide both physical and psychological care from diagnosis to treatment and rehabilitation.
• Asian Cancer Centers LimitedcoreStrategic or Co-development Partner · 10 June 2015Entry into collaboration agreement with Asian Cancer Centers Limited for cancer care services, with update on use of IPO proceeds.
• Medical Centre in Hanoi, VietnamregionalStrategic or Co-development Partner · 29 March 2014Incorporation of subsidiary in Singapore and agreement to operate a medical centre in Hanoi, Vietnam.

Scale indicators3 records

Recent moves8 records

Expansion highlights4 records

Direct peers

• Asian Cancer Centers Limited: TalkMed's 2015 collaboration partner for cancer care services. Competes with TalkMed in private-sector medical oncology across Singapore and potentially the region, with overlapping tumor-type specialties.
• Singapore Medical Group Limited: SGX-listed specialist medical practice group operating across multiple tertiary disciplines (including oncology) within Singapore's private sector. Closely comparable business model: group of specialist doctors delivering tertiary outpatient care.
• Raffles Medical Group: Singapore-listed integrated private healthcare provider offering specialist outpatient services across multiple disciplines, including oncology. Direct domestic peer to TalkMed in Singapore's private healthcare market with similar specialist-practice model.

Broad incumbents

• Apollo Hospitals Enterprise Limited: Asia's largest private hospital chain, operating specialty oncology programs across India and the Middle East. Comparable as a multi-specialty tertiary provider expanding cross-border specialty cancer care.
• IHH Healthcare Berhad: Owner of Parkway Pantai, the network under which Parkway Cancer Centre operates. TalkMed is effectively a tenant/clinical partner inside IHH's platform, and IHH competes broadly for the same oncology patient referrals in Singapore and the region.
• Fortis Healthcare Limited: Pan-Asian private hospital operator with specialty oncology offerings in India, Singapore, and Vietnam. Comparable international specialty-hospital footprint overlapping with TalkMed's Singapore-Vietnam-Hong Kong exposure.
• Mount Elizabeth Cancer Centre (Parkway Pantai): Within the same Parkway Pantai network that TalkMed serves, Mount Elizabeth operates an in-house multidisciplinary cancer service that competes for the same private oncology patients and specialist talent pool in Singapore.

Emerging players

• Icon Group: Australia-headquartered specialty oncology provider with growing Asia-Pacific footprint. Comparable as a doctor-led, multi-modality oncology services group operating outside the public hospital system.
• Novena Global Healthcare Group: Singapore-based specialist medical group offering private oncology and tertiary services. Comparable in operating model to TalkMed as a private specialist practice serving oncology and adjacent specialties in Singapore.
• GenesisCare: Global private oncology provider (radiation, medical oncology, and theranostics) with presence in Australia, the US, the UK, and Spain. Comparable specialty oncology operating model and cross-border expansion pattern.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/talkmed-group-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TALKMED GROUP LTD